Internal Control Weaknesses and Acquisition Performance

Nancy L. Harp, Beau Grant Barnes

The Accounting Review · 2017 · 105 citations · 64 references

DOIFull text

Open access

Concepts

TL;DR

This study examines internal control weaknesses reported under Sarbanes‑Oxley Section 302 in the context of mergers and acquisitions. The study predicts that internal control weaknesses in an acquirer’s environment adversely affect acquisition performance. The authors argue that low‑quality internal information and monitoring impairments caused by ICWs lead to poorer acquisition decisions and hinder integration tasks. ICWs disclosed before an acquisition announcement predict significantly lower post‑acquisition operating performance and abnormal stock returns, particularly those that impede forecasting, monitoring, and integration, thereby linking ineffective internal control to negative operational outcomes and highlighting a new benefit of ICW disclosures for the SOX cost‑benefit debate.

Abstract

ABSTRACT This study examines internal control weaknesses (ICWs) reported under Sarbanes-Oxley (SOX) Section 302 in the context of mergers and acquisitions. We predict that problems in an acquirer's internal control environment have adverse operational implications for acquisition performance. We argue that acquirers with low-quality internal information needed to select profitable acquisitions will make poorer acquisition decisions. We also argue that ICWs impede effective monitoring and are likely to hinder integration tasks that are important to acquisition profitability. We find that ICWs disclosed prior to an acquisition announcement predict significantly lower post-acquisition operating performance and abnormal stock returns. Poorer post-acquisition performance is concentrated in ICWs that are expected to impede acquisition activities (i.e., forecasting/valuation, monitoring, and integration). Our findings contribute to the literature linking ineffective internal control over financial reporting to negative operational outcomes. We also contribute to the SOX cost-benefit debate by documenting a previously unidentified benefit of ICW disclosures.

References

64